Kimberly-Clark reports IFP segment as discontinued after Suzano joint venture

Published 26/07/2025, 06:14
Kimberly-Clark reports IFP segment as discontinued after Suzano joint venture

Kimberly-Clark Corporation (NASDAQ:KMB), currently trading near its 52-week low at $127.38 and commanding a market capitalization of $42.27 billion, disclosed Friday that it has begun reporting its former International Family Care and Professional (IFP) segment as discontinued operations, following a previously announced agreement with Suzano S.A. to form a joint venture.

According to a statement in the company’s SEC filing, Suzano and certain of its subsidiaries will acquire a 51% interest in the joint venture for approximately $1.7 billion, subject to closing adjustments. Kimberly-Clark will retain a 49% equity interest in the new entity, which will be comprised of substantially all operations of the IFP segment.

The company stated that this transaction represents a strategic shift expected to have a major effect on its operations and financial results. As a result, effective in the second quarter of fiscal 2025, the IFP business results are now reported as discontinued operations in the company’s condensed consolidated financial statements.

To assist investors in comparing historical results, Kimberly-Clark is providing supplemental financial information reflecting the IFP business as discontinued operations. The company’s common stock continues to be listed on the Nasdaq Stock Market under the ticker KMB.

This information is based on a statement in a press release included in the company’s SEC filing.

In other recent news, Suzano S.A. has announced the acquisition of a majority stake in Kimberly-Clark Corp.’s international tissue assets for $1.7 billion. This deal, which includes 22 production assets across 14 countries, is expected to increase Suzano’s tissue capacity by 1 million tons and reduce its cash flow volatility. S&P Global Ratings revised Suzano’s outlook to positive following this announcement. Additionally, Suzano and Kimberly-Clark have formed a strategic partnership to create a leading international tissue and professional products company. This joint venture, valued at $3.4 billion, will see Suzano holding a 51% stake and Kimberly-Clark retaining 49%.

Kimberly-Clark is also reportedly nearing the sale of its Kleenex division outside North America for approximately $3.5 billion, with Suzano as the prospective buyer. This move aligns with Kimberly-Clark’s strategy to focus on more profitable areas. In another development, Kimberly-Clark has promoted Russ Torres to President and COO, effective immediately. Torres, who has been with the company since 2020, will oversee daily operations, including the Global Supply Chain and R&D. His leadership has previously contributed to significant growth in Kimberly-Clark’s North America business.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.